DOI: 10.12890/2024_004866
Nebivolol-induced hepatoxicity: a case report
Authors
elias.fiani@hotmail.com
Keywords
Nebivolol, hepatotoxicityAbstract
Nebivolol is a third-generation beta-blocker known for its high selectivity for beta-1 adrenergic receptors and its unique ability to induce vasodilation via nitric oxide (NO) release. Nebivolol, despite its favourable safety profile, can lead to significant liver injury. We describe the case of a 73-year-old hypertensive patient who developed significant liver enzyme elevations following the addition of nebivolol to her treatment regimen. Comprehensive workup ruled out other causes, leading to a diagnosis of drug-induced hepatotoxicity. Discontinuation of nebivolol resulted in normalization of liver enzymes. This case underscores the importance of monitoring liver function during beta-blocker therapy, particularly with nebivolol.
References
- Priyadarshni S, Curry BH. Nebivolol. [Updated 2024 May 6]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551582/
- Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. J Hypertens. 2002;20:1793-1797.
- Briasoulis A, Oliva R, Kalaitzidis R, Flynn C, Lazich I, Schlaffer C, et al. Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study. Clin Hypertens (Greenwich) 2013;15:473-479.
- David S, Hamilton JP. Drug-induced Liver Injury. US Gastroenterol Hepatol Rev 2010;6:73-80.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Nebivolol. [Updated 2017 Jan 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548386/
- Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol 2015;31:184-191.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Metoprolol. [Updated 2017 Jan 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547984/
